3/28
04:19 pm
glpg
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders' Meetings [Yahoo! Finance]
Neutral
Report
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders' Meetings [Yahoo! Finance]
3/28
04:01 pm
glpg
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
Low
Report
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
3/26
04:01 pm
glpg
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
Low
Report
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
3/18
11:06 pm
glpg
Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/18
10:47 am
glpg
Down -14.35% in 4 Weeks, Here's Why Galapagos NV (GLPG) Looks Ripe for a Turnaround [Yahoo! Finance]
Low
Report
Down -14.35% in 4 Weeks, Here's Why Galapagos NV (GLPG) Looks Ripe for a Turnaround [Yahoo! Finance]
3/7
08:02 am
glpg
Galapagos NV (NASDAQ: GLPG) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $38.00 price target on the stock.
Low
Report
Galapagos NV (NASDAQ: GLPG) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $38.00 price target on the stock.
3/2
02:02 am
glpg
Galapagos NV (NASDAQ: GLPG) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Galapagos NV (NASDAQ: GLPG) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/24
08:38 am
glpg
Galapagos NV (NASDAQ:GLPG) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Galapagos NV (NASDAQ:GLPG) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/23
11:06 pm
glpg
Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
2/22
04:11 pm
glpg
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline [Yahoo! Finance]
Medium
Report
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline [Yahoo! Finance]
2/22
04:11 pm
glpg
Galapagos announces full year 2023 results and outlook for 2024 [Yahoo! Finance]
Medium
Report
Galapagos announces full year 2023 results and outlook for 2024 [Yahoo! Finance]
2/22
04:01 pm
glpg
Galapagos announces full year 2023 results and outlook for 2024
Medium
Report
Galapagos announces full year 2023 results and outlook for 2024
2/22
04:01 pm
glpg
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
Medium
Report
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
2/15
04:14 pm
glpg
Galapagos presents at EBMT-EHA annual meeting 2024 [Yahoo! Finance]
Low
Report
Galapagos presents at EBMT-EHA annual meeting 2024 [Yahoo! Finance]
2/15
04:01 pm
glpg
Galapagos presents at EBMT-EHA annual meeting 2024
Low
Report
Galapagos presents at EBMT-EHA annual meeting 2024
2/5
10:03 pm
glpg
Galapagos NV (NASDAQ: GLPG) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Galapagos NV (NASDAQ: GLPG) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
2/5
07:08 am
glpg
NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer [Yahoo! Finance]
Low
Report
NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer [Yahoo! Finance]
1/31
04:01 pm
glpg
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
Low
Report
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
1/5
10:05 pm
glpg
Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
1/4
04:14 pm
glpg
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S. [Yahoo! Finance]
Low
Report
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S. [Yahoo! Finance]
1/4
04:01 pm
glpg
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.
Low
Report
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.
1/3
04:14 pm
glpg
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology [Yahoo! Finance]
Low
Report
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology [Yahoo! Finance]
1/3
04:10 pm
glpg
BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets [Yahoo! Finance]
Low
Report
BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets [Yahoo! Finance]
1/3
04:01 pm
glpg
BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets
Low
Report
BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets
1/3
04:01 pm
glpg
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology
Low
Report
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology